Streptococcus Pneumoniae Infection Clinical Trial
Official title:
Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants Aged 2 Months (at Least 6 Weeks) and 3 Months
This study is a phase III clinical trial to evaluate the immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine (multivalent conjugate) in infants aged 2 months (at least 6 weeks) and 3 months. The main objectives of the study include: 1. To evaluate the immunogenicity of the trial vaccine in infants aged 2 months (at least 6 weeks) following the corresponding immunization schedule compared to the control vaccine; 2. To evaluate the immunogenicity of the trial vaccine in infants aged 3 months following the corresponding immunization schedule compared to the 2-month group; 3. To evaluate the safety of the trial vaccine in infants aged 2 months (at least 6 weeks) and 3 months following the corresponding immunization schedule.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05060146 -
Prevention of Pneumococcal Infections: Impact Collaborative Medico-pharmaceutical Care Structured to Improve Vaccination Coverage of Patients at Risk.
|
N/A | |
Not yet recruiting |
NCT05017519 -
Epidemiology and Household Transmission of Streptococcus Pneumoniae and Respiratory Syncytial Virus
|
||
Completed |
NCT05361499 -
A Controlled Human Pneumococcal Infection Model (PIM) Study
|
N/A | |
Active, not recruiting |
NCT03489018 -
The Effect of Fractional Doses of Pneumococcal Conjugate Vaccines on Immunogenicity and Carriage in Kenyan Infants
|
Phase 4 | |
Completed |
NCT03696303 -
Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
|
||
Active, not recruiting |
NCT03102840 -
Understanding Pneumococcal Carriage and Disease 2017-2020
|
||
Completed |
NCT00189020 -
Effect of Two Versus Three Pneumococcal Conjugate Vaccinations
|
Phase 3 | |
Completed |
NCT02037984 -
Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04944719 -
Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases.
|
||
Completed |
NCT03384589 -
CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study
|
Phase 2/Phase 3 |